Aemetis (NASDAQ:AMTX) Stock Price Crosses Below 200-Day Moving Average of $4.28

Aemetis, Inc. (NASDAQ:AMTX)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.28 and traded as low as $3.92. Aemetis shares last traded at $4.14, with a volume of 559,894 shares traded.

Analysts Set New Price Targets

AMTX has been the subject of a number of research reports. Truist Financial decreased their target price on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating for the company in a research note on Tuesday, January 23rd. Stifel Nicolaus reduced their price objective on Aemetis from $8.00 to $6.50 and set a “buy” rating for the company in a research report on Wednesday, February 21st.

Aemetis Price Performance

The company’s 50-day simple moving average is $4.20 and its two-hundred day simple moving average is $4.28. The firm has a market capitalization of $176.74 million, a P/E ratio of -3.14 and a beta of 1.16.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings data on Thursday, March 7th. The specialty chemicals company reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.01. The company had revenue of $70.76 million during the quarter, compared to analysts’ expectations of $80.08 million. During the same quarter last year, the company earned ($0.63) earnings per share. Analysts predict that Aemetis, Inc. will post -1.52 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in AMTX. SG Americas Securities LLC bought a new position in shares of Aemetis during the 1st quarter valued at approximately $60,000. State Board of Administration of Florida Retirement System purchased a new position in Aemetis during the first quarter valued at approximately $84,000. Barclays PLC purchased a new position in Aemetis during the third quarter valued at approximately $150,000. Sonora Investment Management Group LLC bought a new position in shares of Aemetis in the third quarter worth approximately $166,000. Finally, Citigroup Inc. increased its stake in shares of Aemetis by 10,391.3% in the third quarter. Citigroup Inc. now owns 75,013 shares of the specialty chemicals company’s stock worth $311,000 after purchasing an additional 74,298 shares in the last quarter. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.